Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Piccart, Martine J.
740  Ergebnisse:
Personensuche X
?
1

Progression-free survival assessment by local investigators..:

Jacobs, Flavia ; Molinelli, Chiara ; Martins-Branco, Diogo...
European Journal of Cancer.  197 (2024)  - p. 113478 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Author Correction: Safety analyses from the phase 3 ASCENT ..:

Rugo, Hope S. ; Tolaney, Sara M. ; Loirat, Delphine...
npj Breast Cancer.  10 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
3

Emerging treatments in HER2-positive advanced breast cancer..:

Agostinetto, Elisa ; Curigliano, Giuseppe ; Piccart, Martine
Cell Reports Medicine.  5 (2024)  6 - p. 101575 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Tailoring neo/adjuvant systemic therapy in breast cancer: "..:

Elghazaly, Hesham ; Azim, Hamdy A. ; Rugo, Hope S....
Cancer.  , 2024
Link: https://doi.org/10.1002/..
 
?
5

Tailoring the optimal duration of the extended adjuvant end..:

Pala, Laura ; De Pas, Tommaso ; Pagan, Eleonora...
The Breast.  69 (2023)  - p. 258-264 , 2023
Link: https://doi.org/10.1016/..
 
?
6

PB2707: ESMO-MAGNITUDE OF CLINICAL BENEFIT SCALE FOR HAEMAT..:

Kiesewetter, Barbara ; Dafni, Urania ; de Vries, Elisabeth G E...
HemaSphere.  7 (2023)  S3 - p. e02308e3 , 2023
Link: https://doi.org/10.1097/..
 
?
7

International research to address the challenges of metasta..:

Caballero, Carmela ; Irrthum, Alexandre ; Goulioti, Theodora...
npj Breast Cancer.  9 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
8

Real-world clinical outcomes of patients with stage I HER2-..:

Debien, Veronique ; Marta, Guilherme Nader ; Agostinetto, Elisa...
Critical Reviews in Oncology/Hematology.  190 (2023)  - p. 104089 , 2023
Link: https://doi.org/10.1016/..
 
?
9

Anthracycline-containing and taxane-containing chemotherapy..:

Braybrooke, Jeremy ; Bradley, Rosie ; Gray, Richard...
The Lancet.  401 (2023)  10384 - p. 1277-1292 , 2023
Link: https://doi.org/10.1016/..
 
?
10

Immunological and clinicopathological features predict HER2..:

Rediti, Mattia ; Fernandez-Martinez, Aranzazu ; Venet, David...
Nature Communications.  14 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
11

Obesity-associated changes in molecular biology of primary ..:

Nguyen, Ha-Linh ; Geukens, Tatjana ; Maetens, Marion...
Nature Communications.  14 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
12

Ten-year survival of neoadjuvant dual HER2 blockade in pati..:

Nuciforo, Paolo ; Townend, John ; Piccart, Martine J....
European Journal of Cancer.  181 (2023)  - p. 92-101 , 2023
Link: https://doi.org/10.1016/..
 
?
13

Health-related quality of life in the phase III ASCENT tria..:

Loibl, Sibylle ; Loirat, Delphine ; Tolaney, Sara M....
European Journal of Cancer.  178 (2023)  - p. 23-33 , 2023
Link: https://doi.org/10.1016/..
 
?
14

Safety analyses from the phase 3 ASCENT trial of sacituzuma..:

Rugo, Hope S. ; Tolaney, Sara M. ; Loirat, Delphine...
npj Breast Cancer.  8 (2022)  1 - p. , 2022
Link: https://doi.org/10.1038/..
 
?
15

Sacituzumab govitecan as second-line treatment for metastat..:

Carey, Lisa A. ; Loirat, Delphine ; Punie, Kevin...
npj Breast Cancer.  8 (2022)  1 - p. , 2022
Link: https://doi.org/10.1038/..
 
1-15